New Jersey DME Company Agrees to Permanent Exclusion

On September 7, 2016, in connection with the resolution of False Claims Act liability, Oxford Diabetic Supply, Inc. (Oxford), agreed to be permanently excluded from participating in Federal health care programs under 42 U.S.C. § 1320a-7(b)(7). OIG alleged that Oxford set up and controlled an entity that it used to make unsolicited telephone calls to suspected Medicare beneficiaries in order to sell durable medical equipment (DME) to those beneficiaries, in violation of the Social Security Act's DME Telemarketing Provisions. OIG alleged that Oxford billed Medicare for DME that was sold pursuant to these unsolicited calls. Associate Counsel David Fuchs represented OIG.

Share